WUXI BIOLOGICS (CAYMAN) INC revenue breakdown overview

WUXI BIOLOGICS (CAYMAN) INC revenue for the last year amounted to 18.74 B HKD, the most of which — 14.84 B HKD — came from its highest performing source at the moment, Research Services on Fee-for-Service, the year earlier bringing 9.68 B HKD. The greatest contribution to the revenue figure was made by North America — last year it brought WUXI BIOLOGICS (CAYMAN) INC 9.88 B HKD, and the year before that — 6.30 B HKD.